🦜 (multiple sclerosis[TIAB] AND microglia [TIAB] AND (modulate [tiab] OR therapy [tiab]) )
@pubmed.ncbi.nlm.nih.gov.rss-feed.feed.id.1fu8xzk4yhhewwxhjpj0wias65oqqskkl3us0d7kijxyjifeei.utm.content.1fu8xzk4yhhewwxhjpj0wias65oqqskkl3us0d7kijxyjifeei.utm.source.rss-parrot-bot.ff.20260423183435.utm.medium.rss.v.2.19.0.post6.133c1fe@rss-parrot.net
I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline!
Brought to you by the RSS Parrot.
---
(multiple sclerosis[TIAB] AND microglia [TIAB] AND (modulate [tiab] OR therapy [tiab]) ): Latest results from PubMed
Your feed and you don't want it here? Just
e-mail the birb.
Microglia in Alzheimer's disease: from pathogenic mechanisms to therapeutic targeting
https://pubmed.ncbi.nlm.nih.gov/43005561/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261110140333&v=2.20.1
Published: November 10, 2026 11:00
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder driven by β-amyloid (Aβ) deposition, tau hyperphosphorylation, synaptic dysfunction, neuroinflammation, vascular injury, and metabolic dysregulation. Recent advances in single-cell,…
Neuroinflammation in Alzheimer's disease: pathogenic signaling, biomarkers, and emerging therapeutic interventions
https://pubmed.ncbi.nlm.nih.gov/42996505/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261108020803&v=2.20.1
Published: November 7, 2026 11:00
Alzheimer's disease (AD) is the leading cause of dementia worldwide, characterized by progressive cognitive decline and neurodegeneration. Although amyloid-β plaques and hyperphosphorylated tau are major pathological hallmarks, increasing evidence…
Noncanonical Signaling Network of Nogo-A: A New Perspective on Multi-target Regulation, Neuroplasticity, and Disease Intervention Beyond NgR
https://pubmed.ncbi.nlm.nih.gov/42980722/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261104195845&v=2.20.1
Published: November 4, 2026 11:00
The membrane protein Nogo-A, initially identified for its inhibitory role in axonal regeneration through the Nogo receptor (NgR), is now recognized as a central hub in a complex noncanonical signaling network. Recent evidence indicates that Nogo-A engages…
Photobiomodulation as a regulator of neuroinflammation: mechanistic insights and therapeutic potential in brain disorders
https://pubmed.ncbi.nlm.nih.gov/42964993/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261101004546&v=2.20.1
Published: October 31, 2026 10:00
Brain disorders, including neurodegenerative, neuropsychiatric, and cerebrovascular diseases, represent a growing global health challenge contributing to disability and mortality worldwide. Although these conditions differ in etiology and clinical…
Combining pharmacological and non-invasive brain stimulation strategies to promote remyelination in multiple sclerosis
https://pubmed.ncbi.nlm.nih.gov/42952812/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261029165309&v=2.20.1
Published: October 29, 2026 10:00
Remyelination in multiple sclerosis (MS) fails for several, partly overlapping reasons. The differentiation of oligodendrocyte precursor cells into myelin-producing oligodendrocytes is impaired both by intrinsic factors and by the surrounding lesion…
Exploring Progressive Multiple Sclerosis and the Therapeutic Potential of BTK Inhibitors Based on EBV-driven B Cell-microglia Interactions
https://pubmed.ncbi.nlm.nih.gov/42861741/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261012124659&v=2.20.1
Published: October 12, 2026 10:00
Progressive Multiple Sclerosis (PMS) remains a major cause of irreversible disability in Multiple Sclerosis (MS), yet current disease-modifying therapies incompletely address the compartmentalized Central Nervous System (CNS) inflammation, sustained…
The ACOD1-itaconate axis in anti-neuroinflammation and protection against neurodegenerative diseases
https://pubmed.ncbi.nlm.nih.gov/42853245/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261009124930&v=2.20.1
Published: October 9, 2026 10:00
Chronic neuroinflammation mediated by activated microglia constitutes a central pathogenic mechanism underlying neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Despite substantial…
The Role of Mast Cells and Their Potential as a Therapeutic Target For Neuroinflammation
https://pubmed.ncbi.nlm.nih.gov/42835139/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20261006150149&v=2.20.1
Published: October 6, 2026 10:00
Neuroinflammation is increasingly recognized as a central mechanism underlying the onset and progression of numerous neurological disorders, including neurodegenerative, autoimmune, and cerebrovascular diseases. Although microglia and astrocytes are…
Impact of Oral Cladribine on TSPO-PET-Measurable Immune Cell Activation in Multiple Sclerosis
https://pubmed.ncbi.nlm.nih.gov/42814343/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20260930204515&v=2.20.1
Published: September 30, 2026 10:00
CONCLUSION: TSPO-binding in the NAWM increased during oral cladribine treatment despite suppressed relapses and decreased sNfL Z-score. These exploratory findings raise the possibility that cladribine may have limited ability to control smoldering…
Shedding Light on Interaction Between Neurological Symptoms and Psychiatric Episodes in Multiple Sclerosis: Novel Hypothesis and Therapeutic Avenues
https://pubmed.ncbi.nlm.nih.gov/42762287/?utm_source=RSS-Parrot-Bot&utm_medium=rss&utm_campaign=None&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&fc=None&ff=20260920043244&v=2.20.1
Published: September 19, 2026 10:00
Multiple sclerosis is a chronic neuroinflammatory disorder, with different central nervous system lesions being induced at distinct time points. Anxiety disorders and major depressive disorder are common comorbidities of multiple sclerosis. In such cases,…